Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Mortality associated with proton pump inhibitors in cirrhotic patients with spontaneous bacterial peritonitis.

Kwon JH, Koh SJ, Kim W, Jung YJ, Kim JW, Kim BG, Lee KL, Im JP, Kim YJ, Kim JS, Yoon JH, Lee HS, Jung HC.

J Gastroenterol Hepatol. 2014 Apr;29(4):775-81. doi: 10.1111/jgh.12426.

PMID:
24219827
2.

Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.

Mandorfer M, Bota S, Schwabl P, Bucsics T, Pfisterer N, Summereder C, Hagmann M, Blacky A, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Reiberger T.

PLoS One. 2014 Nov 4;9(11):e110503. doi: 10.1371/journal.pone.0110503. eCollection 2014.

3.

Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.

Goel GA, Deshpande A, Lopez R, Hall GS, van Duin D, Carey WD.

Clin Gastroenterol Hepatol. 2012 Apr;10(4):422-7. doi: 10.1016/j.cgh.2011.11.019. Epub 2011 Dec 7.

PMID:
22155557
4.

Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Bajaj JS, Zadvornova Y, Heuman DM, Hafeezullah M, Hoffmann RG, Sanyal AJ, Saeian K.

Am J Gastroenterol. 2009 May;104(5):1130-4. doi: 10.1038/ajg.2009.80. Epub 2009 Mar 31.

PMID:
19337238
5.

Acid-suppressive therapy is associated with spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis.

Deshpande A, Pasupuleti V, Thota P, Pant C, Mapara S, Hassan S, Rolston DD, Sferra TJ, Hernandez AV.

J Gastroenterol Hepatol. 2013 Feb;28(2):235-42. doi: 10.1111/jgh.12065. Review.

PMID:
23190338
6.

Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.

de Vos M, De Vroey B, Garcia BG, Roy C, Kidd F, Henrion J, Deltenre P.

Liver Int. 2013 Oct;33(9):1316-23. doi: 10.1111/liv.12210. Epub 2013 Jun 3.

PMID:
23730823
7.

Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis.

Kim JJ, Tsukamoto MM, Mathur AK, Ghomri YM, Hou LA, Sheibani S, Runyon BA.

Am J Gastroenterol. 2014 Sep;109(9):1436-42. doi: 10.1038/ajg.2014.212. Epub 2014 Aug 5.

PMID:
25091061
8.

Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.

Miura K, Tanaka A, Yamamoto T, Adachi M, Takikawa H.

Intern Med. 2014;53(10):1037-42.

9.

Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Choi EJ, Lee HJ, Kim KO, Lee SH, Eun JR, Jang BI, Kim TN.

Scand J Gastroenterol. 2011 May;46(5):616-20. doi: 10.3109/00365521.2011.551891. Epub 2011 Jan 31.

PMID:
21275825
10.

[The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].

Wang X, Wang BM, Jiang K, Zhang J, Fang WL, Wang T, Li XY.

Zhonghua Nei Ke Za Zhi. 2009 Aug;48(8):629-32. Chinese.

PMID:
19954052
11.

Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.

Min YW, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.

Aliment Pharmacol Ther. 2014 Sep;40(6):695-704. doi: 10.1111/apt.12875. Epub 2014 Jul 30.

12.

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.

Schwabl P, Bucsics T, Soucek K, Mandorfer M, Bota S, Blacky A, Hirschl AM, Ferlitsch A, Trauner M, Peck-Radosavljevic M, Reiberger T.

Liver Int. 2015 Sep;35(9):2121-8. doi: 10.1111/liv.12795. Epub 2015 Feb 18.

PMID:
25644943
13.

Association between model for end-stage liver disease and spontaneous bacterial peritonitis.

Obstein KL, Campbell MS, Reddy KR, Yang YX.

Am J Gastroenterol. 2007 Dec;102(12):2732-6. Epub 2007 Aug 21.

PMID:
17714556
14.

Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.

Ratelle M, Perreault S, Villeneuve JP, Tremblay L.

Can J Gastroenterol Hepatol. 2014 Jun;28(6):330-4.

15.

Prognostic factors associated with in-hospital mortality in patients with spontaneous bacterial peritonitis.

Musskopf MI, Fonseca FP, Gass J, de Mattos AZ, John JA, de Mello Brandão AB.

Ann Hepatol. 2012 Nov-Dec;11(6):915-20.

16.

Association between proton pump inhibitor use and spontaneous bacterial peritonitis.

Campbell MS, Obstein K, Reddy KR, Yang YX.

Dig Dis Sci. 2008 Feb;53(2):394-8. Epub 2007 Jul 7.

PMID:
17616817
17.

The 22/11 risk prediction model: a validated model for predicting 30-day mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Tandon P, Kumar D, Seo YS, Chang HJ, Chaulk J, Carbonneau M, Qamar H, Keough A, Mansoor N, Ma M.

Am J Gastroenterol. 2013 Sep;108(9):1473-9. doi: 10.1038/ajg.2013.204. Epub 2013 Jul 23.

PMID:
23877350
18.

Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.

Xu HB, Wang HD, Li CH, Ye S, Dong MS, Xia QJ, Zhang AQ, Pan K, Ge XL, Dong JH.

Genet Mol Res. 2015 Jul 6;14(3):7490-501. doi: 10.4238/2015.July.3.25. Review.

19.

Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.

Terg R, Casciato P, Garbe C, Cartier M, Stieben T, Mendizabal M, Niveyro C, Benavides J, Marino M, Colombato L, Berbara D, Silva M, Salgado P, Barreyro F, Fassio E, Gadano A; Study Group of Cirrhosis Complications of the Argentine Association for the Study of Liver Disease.

J Hepatol. 2015 May;62(5):1056-60. doi: 10.1016/j.jhep.2014.11.036. Epub 2014 Dec 4.

PMID:
25481567
20.

Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial Peritonitis.

Ensaroğlu F, Korkmaz M, Geçkil AÜ, Öcal S, Koç B, Yıldız Ö, Atalay FB, Taş EG, Haberal M.

Exp Clin Transplant. 2015 Nov;13 Suppl 3:131-6.

Supplemental Content

Support Center